Qinghai Ji

机构：Fudan University Shanghai Cancer Center · ORCID：0000-0003-1006-8503

发表论文 121 篇 · 总被引 2379 次 · h-index 27

代表论文

• TERT accelerates BRAF mutant–induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis (2023 · Science Advances · 被引 70)
• A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer (2024 · JCI Insight · 被引 52)
• The Efficacy and Safety of Surufatinib Combined with Anti PD-1 Antibody Toripalimab in Neoadjuvant Treatment of Locally Advanced Differentiated Thyroid Cancer: A Phase II Study (2023 · Annals of Surgical Oncology · 被引 25)
• Efficacy and safety of selpercatinib in Chinese patients with advanced RET -altered thyroid cancers: results from the phase II LIBRETTO-321 study (2022 · Therapeutic Advances in Medical Oncology · 被引 18)
• Targeting Tumor Hypoxia Inhibits Aggressive Phenotype of Dedifferentiated Thyroid Cancer (2022 · The Journal of Clinical Endocrinology & Metabolism · 被引 15)
• PRDM16 Inhibits Cell Proliferation and Migration via Epithelial-to-Mesenchymal Transition by Directly Targeting Pyruvate Carboxylase in Papillary Thyroid Cancer (2021 · Frontiers in Cell and Developmental Biology · 被引 10)